Mononuclear phagocytes (MO) produce urokinase-type plasminogen activator (uPA) and also express a specific cell-surface receptor for urokinase, uPAR. The concomitant expression of these proteins provides a mechanism by which MO can degrade extracellular matrix proteins during directed cell migration. In this study, we sought to determine if uPAR plays a role in MO chemotaxis that is distinct from its role in matrix proteolysis. Exposing adherent monocytes to a chemotactic gradient causes plasma membrane uPAR to localize strongly to the leading edge of cell migration. Adherence alone or exposure to FMLP had no effect on uPAR expression. Using Boyden chamber chemotaxis assays, we demonstrate that treating mononuclear cells with an anti-uPAR mAb (either as an intact mAb or Flab'12) ablates chemotaxis induced by FMLP and monocyte chemotactic peptide-1 (P < 0.001). Inactivating the catalytic activity of uPAR-bound uPA had no effect on chemotaxis. Similarly, blocking uPAR expression with an antisense oligonucleotide to uPAR completely ablates chemotaxis, but blocking uPA expression with an antisense oligonucleotide to uPA has a minimal effect. We therefore demonstrate that expression and unimpeded function of uPAR plays an obligate role in M6 chemotaxis by mechanisms that are largely independent of its ligand, uPA. Combined with its known role in mediating pericellular proteolysis, these observations demonstrate that uPAR is essential for both locomotion and traversing tissue barriers during MO migration. (J. Clin. Invest. 1994.
Introduction
For monocytes to be successfully recruited to inflammatory sites, at least two distinct functions are required. First, they must accomplish directional migration in a chemotactic gradient. This complex process requires a sequence of adhesion, cytoskeletal rearrangement, movement, and detachment steps ( 1, 2) . Second, cells often traverse tissue planes, a process that may require expression of extracellular proteases to degrade specific extracellular matrix (ECM)' proteins (3) (4) (5) . One mechanism by which leukocytes can promote ECM degradation is by converting plasminogen to plasmin through the action of urokinase-type plasminogen activator (uPA) (6, 7) .
Mononuclear phagocytes (MO) produce uPA and also express specific high affinity cell-surface receptors for uPA (uPAR) (4, (7) (8) (9) . This receptor allows uPA to function as a membrane-associated ectoenzyme, thereby limiting proteolysis to the immediate pericellular environment (4, 10) . Both Mq and a variety of malignant cells have been shown to use uPAR-associated uPA to degrade matrix proteins during tissue invasion (3, 1 1, 12) . Although ECM degradation requires catalytically active uPA, it is not known whether uPA and uPAR are involved in other mechanisms necessary for cell movement.
Several intriguing observations support a role for uPAR in cell locomotion. In malignant cells, uPAR localizes to cellular binding sites to ECM, where it colocalizes with cytoskeletal components such as vinculin (13) (14) (15) . This suggests that uPAR may participate in a transmembrane structure that links the ECM with the cell surface and cytoskeleton. Increased uPAR and uPA expression has recently been described in migrating endothelial cells ( 16) . One antibody to uPAR inhibits MO responsiveness to migration inhibition factor, providing another potential association between uPAR and cell movement ( 17) . The uPA-uPAR system is known to affect leukocyte behavior by mechanisms unrelated to plasminogen activation. uPA can directly cleave ECM components and can act as a chemotaxin for neutrophils and as a mitogen for lymphocytes (18) (19) (20) . Also, uPA and plasmin play important roles in modulating cytokine release and activity (21, 22) . A portion of the uPA molecule, the growth factor domain, may trigger MO differentiation and adhesion by binding to uPAR (23) .
In this study, we sought to determine ifuPAR plays a role in cellular migration that is distinct from its participation in ECM proteolysis. We show that human monocytes alter the plasma membrane distribution of uPAR on exposure to a chemotactic gradient, as uPAR becomes tightly localized to the leading edge ofmigration. Adhesion on plastic alone and exposure to FMLP have no effect on total uPAR expression. We (31, 32) . Controls included oligonucleotides of random sequence and length, sense (S)-uPAR, and nonsense (NS)-uPAR (same base composition of AS-uPAR, but in random order). AS-, S-, and NS-oligos were synthesized by the DNA Synthesis Core of the University of Michigan on automated DNA synthesizers, substituting sulfur for oxygen at the phosphate moiety. These phosphorothioate oligonucleotides are nuclease resistant (33) . Cells were incubated with 30MM AS-oligos for 24 h at 37°C. Efficacy of AS-oligo treatment was confirmed by demonstrating loss of immunofluorescent staining for the corresponding protein. Cell viability exceeding 95% was confirmed by trypan blue exclusion before using AS-oligo-treated cells in experiments.
Immunolabeling. BMC or purified monocytes were resuspended in staining buffer (PBS with 1% BSA and 0.1% sodium azide, pH 7.4). Immunolabeling for uPA or uPAR was performed by incubating the cells with either an anti-uPA or anti-uPAR primary mAb for 30 min, 4°C, followed by labeling for 30 min, 4C, with FITC-conjugated goat anti-mouse F(ab')2 secondary Ab. Negative control cells were stained with the secondary Ab alone or with an irrelevant isotype-matched primary Ab. For some-experiments, the same labeling procedure was used for fluorescent microscopy of glass-adherent monocytes.
Immunofluorescentflow cytometric analysis. Cells were selected by gating (log forward angle versus log right angle light scatter). Immunofluorescent intensity was assessed as a measure of relative antigen expression using a flow cytometer (EPICS; Coulter Corp., Hialeah, FL) with a logarithmic amplifier. The channel number (log scale) representing the mean fluorescent intensity (major fluorescent peak) was deter- 
Results
Effects ofa chemotactic gradient on the cell-surface distribution ofuPAR. Adherent monocytes were exposed to a chemotactic gradient created by placing a 25-,ul bead of FMLP ( l0-7 M) at one spot on the slide. After 30 min, the cells were stained with anti-uPAR mAb followed by an FITC-conjugated secondary Ab and examined by fluorescent microscopy ( Fig. 1 ). Negative control cells were stained with the secondary Ab alone. Untreated monocytes (not exposed to FMLP) were relatively dull, and the distribution of cell-surface uPAR was homogeneous. However, when the monocytes were exposed to an FMLP gradient, staining for uPAR became granular and strongly localized to the leading edge facing the chemotactic gradient in approximately one-third of the cells. When cells were stained for uPA, a similar pattern of localization towards the chemotactic gradient was observed (not shown). Clustering of surface uPA has been reported previously in 30% of FMLP-exposed monocytes (10) . Thus, monocytes cluster uPAR and endogenously generated uPA toward an area corresponding to the leading edge ofcell migration. It is presently unclear whether clustering of uPAR and uPA occurs, at least transiently, in all migrating cells.
To determine if FMLP stimulation itself affects the quantity of uPAR on the plasma membrane, monocytes were exposed to FMLP for 30 min after adherence to plastic. After incubation, the cells were gently released and immunolabeled, and uPAR expression was quantitated by flow cytometry. Exposure to a range of concentrations of FMLP ( 10-7_ 1 -l 0 M) did not alter the overall expression of uPAR on the monocyte cell surface relative to control cells (mean fluorescence of control 121+17;FMLP 10-7M, 116±9;FMLP 10"-IM, 121±15; P = not significant). 88.8±4.9, P = not significant).
As we were examining membrane redistribution of uPAR in response to FMLP, we attempted to immunolabel uPAR before adhering the monocytes to slides and exposing them to an FMLP gradient. These anti-uPAR-pretreated cells did not exhibit clustering of uPAR toward the chemotactic gradient (not shown). This suggested to us that the anti-uPAR mAb (3B10) interacts with uPAR in a way that prohibits normal uPAR clustering in response to a chemotactic gradient. We therefore questioned whether this anti-uPAR mAb also affected the ability of these cells to migrate toward a chemotactic gradient.
Effects of anti-uPAR and neutralizing anti-uPA mAb on mononuclear cell chemotaxis. We sought to determine whether functional uPAR or catalytically active uPA were required for monocyte chemotaxis in a standard Boyden chamber in the absence of serum and ECM, using FMLP (l0-7 M) as the chemotaxin. Antibodies were titered to determine optimal binding to monocytes, as determined by flow cytometry. AntiuPAR and isotype-matched control mAbs were used at a 1:50 dilution, and anti-uPA was used at 5 ,ug/ I07 cells per milliliter.
Mononuclear cells were incubated in medium alone or were pretreated with either anti-uPAR or anti-uPA mAb before resuspension in medium. The Boyden chambers were incubated for 2 h at 37°C. The number of mononuclear cells that traversed the filter in response to the chemotactic gradient was expressed as the percentage of control cells that did not receive any pretreatment and were exposed to the same chemotactic gradient. Random cell movement and chemokinesis (as defined in Methods) were also measured for each experiment.
As shown in Fig. 2 , incubation with the anti-uPAR mAb dramatically reduces chemotaxis to 14.2±5.0% of untreated cells (P < 0.001). This level of cell migration was comparable with that seen in conditions of random cell movement and chemokinesis (13.9+2.6%, and 6.6±1.9% of control chemotaxis, respectively). In distinct contrast, incubation with neutralizing anti-uPA mAb had no significant effect on mononuclear cell chemotaxis (88.2±10.3% untreated cells, P = 0.3). Further, saturating uPAR occupancy with exogenous HMWuPA (4 ,g/ml) had no effect on chemotaxis (99.9±13.4% untreated cells). Preincubating mononuclear cells with excess HMW-uPA followed by anti-uPAR mAb yielded chemotaxis that was the same as anti-uPAR treatment alone ( I 1 .1±3.3% of untreated cells, P < 0.001 ). Control Abs 949 and 99, which are isotype-type matched with 3B10, but recognize unrelated monocyte antigens, had no effect on chemotaxis. From these data, we conclude that plasma membrane uPAR is required for mononuclear cell chemotaxis in response to FMLP. However, chemotaxis did not require endogenous uPA activity and was not influenced by high concentrations of exogenous catalytically active uPA.
To determine whether these effects pertained only to FMLP-induced chemotaxis, the above studies were repeated using rMCP-1 (50 ng/ml). As shown in Fig. 3 , the results using rMCP-1 were indistinguishable from those using FMLP, demonstrating that treating cells with anti-uPAR mAb decreased chemotaxis to 17.1±8.3% of untreated cells (P < 0.01 ). Again, preincubating cells with anti-uPA mAb had no effect on mononuclear cell chemotaxis compared with untreated cells (97.1±24.6% of untreated cells). Similarly, the addition of HMW-uPA (4 ,g/ml) had no effect on mononuclear cell chemotaxis (90.3±5.6% of untreated cells), and exogenous HMW-uPA did not affect the inhibitory action of anti-uPAR mAb (6.8±5.0% of untreated cells, P < 0.05). Thus, we conclude that the requirement for uPAR, but not uPA activity, is not specific to a single chemotaxin.
Despite the fact that the suppressive effects of anti-uPAR mAb on chemotaxis were not shared by control Abs, we wished to confirm that the effects of anti-uPAR mAb were not partly mediated by the Fc portion of the Ab. We therefore examined the effects of purified anti-uPAR mAb (3B10) F(ab')2 fragments (10 Ig/ I07 cells per milliliter) on chemotaxis. We found that F(ab')2 fragments of the anti-uPAR mAb duplicated the effects of the intact antibody, reducing chemotaxis to 14.2±4.4% of untreated cells (P < 0.001; Fig. 4 8 h before LPS was added and were incubated for a total of 24 h, followed by immunostaining and fluorescent microscopy. Negative control cells were stained with the secondary antibody alone. When cells were cultured in the absence of ASuPAR, there was bright staining for cell-surface uPAR expression (Fig. 6) . However, when cells were incubated with ASuPAR for 24 h, surface uPAR was virtually undetectable on fluorescent microscopy (Fig. 6, top row) . Similarly, when cells were cultured in the absence ofAS-uPA, there was bright staining for cell-surface uPA expression. However, when cells were incubated with AS-uPA for 24 h, cell-surface uPA was markedly diminished (Fig. 6, second row) . Incubating cells with AS-uPA did not block expression of uPAR (Fig. 6 , third row, right), and uPAR was fully able to bind exogenous uPA (Fig. 6 , third row, left).
Having confirmed that AS-oligo blockade of uPAR and uPA was effective and specific, AS-oligo-treated cells were studied in chemotaxis assays. Under all conditions, cells were > 95% viable when the chemotaxis assays were initiated. As shown in Fig. 7 , cells preincubated with AS-uPAR exhibited markedly suppressed chemotaxis, to 23 .2±4.0% of untreated cells (P < 0.001 ), approximating the migration seen in chemokinesis controls. Preincubating cells with AS-uPA had a minor suppressive effect on chemotaxis (85.0±4.2% of untreated AS-uPAR, AS-uPA, or control oligos for 24 h before assessment of chemotaxis by Boyden chamber assay. Data are expressed as percentage of control, mean±SEM. *P < 0.001, **P < 0.006, n = 10. cells, P < 0.01 ). Pretreatment with irrelevant random oligonucleotides, S-uPAR, or NS-uPAR had no effect on chemotaxis. The effect of AS-uPAR on chemotaxis was entirely reversible, as chemotaxis was fully restored to control levels 24-48 h after the cells were removed from AS-uPAR-containing media (n = 3, not shown). Thus, we conclude that blocking uPAR expression on the cell surface with AS-uPAR ablates mononuclear cell chemotaxis to FMLP, while blocking uPA expression has only a relatively small effect. These observations essentially recapitulate the effects of anti-uPAR and anti-uPA mAb on chemotaxis.
Discussion
We have established that monocyte chemotaxis requires the unencumbered expression and function of plasma membrane uPAR. Binding ofthe anti-uPAR mAb 3B 10 or ablating uPAR expression by preincubation with AS-uPAR oligo reduces migration toward a chemotactic gradient to the levels achieved by random movement or chemokinesis (Figs. 2 and 7 ). By contrast, blocking the catalytic site of receptor-bound uPA or suppressing uPA expression with AS-uPA oligo has little or no effect on monocyte chemotaxis (Figs. 2 and 7) . Furthermore, adding exogenous HMW-uPA to increase uPAR-bound uPA has no effect on chemotaxis. These results are not specific to FMLP-induced chemotaxis, since virtually identical results were seen when rMCP-1 was used (Fig. 3) . Exposure to an FMLP gradient causes uPAR and uPA to become highly concentrated at the leading edge of migration (Fig. 1) . It has been shown previously that the binding sites for exogenous uPA cluster at the leading edge ofchemotaxis in monocytes exposed to FMLP ( 10). Our observations confirm these findings by directly examining the distribution of uPAR protein itself as well as uPAR occupied with endogenously generated uPA.
It has been demonstrated conclusively that under some conditions uPA and plasmin figure importantly in the migration of mononuclear phagocytes and neoplastic cells (3, 4, 36, 37) . Plasmin and uPA can degrade ECM glycoproteins, proteoglycans, and adhesion proteins, as well as facilitating destruction ofcollagen and elastin by activating latent matrix metalloproteinases (6, (38) (39) (40) (41) . Rather than examining the known effects of proteolysis of stromal elements, our studies were designed to focus on the potential role of uPA and uPAR in directional movement in response to a chemotaxin. Therefore, we chose to study chemotaxis in the absence of ECM proteins and in the absence of exogenous plasminogen. Although it is likely that uPA is maintained as a single chain proenzyme in this plasminogen-free system, there is evidence that single chain uPA has enhanced catalytic activity when bound to uPAR (42). Using antibody neutralization and AS-uPA, we have shown that uPA and plasmin are not required for locomotion under matrix-free conditions. Further, we observed that high concentrations of exogenous active HMW-uPA did not affect chemotaxis or mitigate the importance of uPAR function in this process, as anti-uPAR mAb-induced blockade of chemotaxis persisted after prior treatment with HMW-uPA (Fig. 2) .
Receptor-associated uPA appeared to have little role in modulatingthe function ofuPAR in chemotaxis. Neither exogenous HMW-uPA nor neutralizing endogenously generated uPA activity with mAb had any effect on chemotaxis, but blocking uPA expression with AS-uPA did diminish chemotaxis to a small but significant degree. Therefore, it appears that uPA-mediated proteolysis does not affect chemotaxis under the conditions described, but uPA binding has at least a modest influence on uPAR function. It is likely, however, that uPA function is critical for chemotaxis under other conditions, particularly where ECM proteins are present (4) .
The mechanism underlying the role of uPAR in cell movement remains to be elucidated. One possibility is that uPAR participates in signal transduction pathways that are required for directional locomotion. uPAR is known to transmit differentiation signals by binding uPA (23) . uPAR is bound to the plasma membrane by a glycosyl phosphatidylinositol (GPI)-linkage and therefore lacks a membrane-spanning domain (26) . Thus, it is likely that uPAR mediates signal transduction indirectly by associating with another surface protein that has a membrane-spanning domain. This hypothesis is particularly attractive since it has been demonstrated recently that ligand binding causes uPAR to associate with a 38-kD partner protein that is phosphorylated on tyrosine (43) . Tyrosine phosphorylation is typical of several signaling pathways associated with growth and differentiation (43, 44) . There are other precedents for such a mechanism for signal transduction involving GPI-linked proteins. CD59, a GPI-anchored protein involved in T cell adhesion and activation, is tightly associated with an 80-kD glycoprotein with protein kinase activity. Also, there are bidirectional interactions between CD 16 (GPIlinked) and CD32 in neutrophils (45) . Partner protein relationships were found for GPI-linked CD55 and for the ciliary neurotrophic factor receptor (44, (46) (47) (48) . The IL-6 receptor, which contains a transmembrane segment, must combine with IL-6 and a partner protein (gp 130) for signal transduction to proceed (49, 50) . It is possible that blocking uPAR expression or function suppresses chemotaxis by preventing a critical association between uPAR and a partner protein, thereby blocking signal transduction.
It is also possible that the obligate role of uPAR in chemotaxis is dependent upon a direct linkage between uPAR and the cytoskeleton. uPAR is known to colocalize with vinculin, a-actinin, and actin at sites ofcontact between cells and ECM ( 14) . ( 14) . Clustering ofuPAR on the plasma membrane may directly induce at least part of the cytoskeletal reorganization that is required for cell movement. Because uPAR expression is required for chemotaxis, it is certainly unlikely that cytoskeletal reorganization is causing associated uPAR to cluster merely as an epiphenomenon. Because anti-uPAR mAb-treated monocytes did not adhere or spread normally, it is also possible that uPAR is required for monocyte adhesion to surfaces as they move toward a chemotaxin. Since uPAR is GPI-linked, it is likely that uPAR and vinculin are bridged by at least one protein that contains a transmembrane segment. It is not known whether the 38-kD partner protein ofuPAR associates with the cytoskeleton (43) . In neutrophils, uPAR has been shown to cocap with CR3 (CDl lb/CD 1 8). CR3 is known to enhance its proximity to actin filaments when it binds ligand (51) . This observation provides a potential mechanism for an interaction of uPAR with the cytoskeleton (52, 53) . Certainly, none ofthese postulated mechanisms for the role ofuPAR in chemotaxis are mutually exclusive. Interactions involving cell activation, adherence, signal transduction, and motility are complex and highly interdependent. In granulocytes, exposure to chemotaxins alters plasma membrane expression ofintegrins, which participate in signal transduction as well as linking directly to the cytoskeleton (54-56). uPAR may likewise be multifunctional, affecting extracellular proteolysis, signal transduction, substrate attachment, and cytoskeletal reorganization in a way that culminates in directional cell movement.
The uPA-uPAR system clearly has effects on inflammatory processes that extend beyond the regulation of local plasminogen activation and matrix remodeling. uPA is able to influence directly many cell types, acting as a chemotaxin for granulocytes, a lymphocyte mitogen, and an angiogenic factor ( 19, 20, 36) . Plasmin can activate TGF-,B from its latent form, stimulate release of IL-1 from MO, inactivate IFN-'y, degrade CDl lb/CD 1 8, and release basic fibroblast growth factor from binding sites in the ECM (22, 41, 57, 58) . uPA itself activates the latent form ofhepatocyte growth factor-scatter factor (59) . Additionally, uPA has autocrine effects, as uPA triggers differentiation of MO and promotes cellular adhesion (23). These observations, however, could not be extended to fully differentiated monocytes or alveolar macrophages. These actions were caused by uPA binding to plasma membrane uPAR by its NH2-terminal region, which contains sequences that are homologous to the receptor-binding domain of EGF. The uPAgrowth factor domain is also responsible for the growth factorlike activity seen in human osteosarcoma and squamous carcinoma cells (60, 61) . By demonstrating that uPAR is also essential for chemotaxis, we extend the importance of uPAR beyond its established roles in anchoring uPA ectoenzyme activity and in signal transduction.
In summary, we have determined that uPAR is required for monocyte chemotaxis in vitro and that this aspect of uPAR function is, in large part, independent ofits ligand, uPA. By its integral role in the machinery ofcellular locomotion, as well as its capacity to focus uPA-and plasmin-mediated proteolysis at the cell surface, uPAR performs two vital and distinct functions in the directional migration of mononuclear phagocytes.
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